Click here for an archive of Cramer's "Mad Money" recaps.
Market players must be prepared for a hard landing next week in case
Chairman Ben Bernanke keeps raising rates, Jim Cramer said on his "Mad Money" TV show Friday.
When we have the expectation that the Fed is going to raise rates, we must run to the supermarkets and drugstores, he said.
Cramer's rough-landing game plan includes three supermarket stocks:
- Hershey (HSY) - Get The Hershey Company Report
- McCormick (MKC) - Get McCormick & Company Incorporated Report
- Kellogg (K) - Get Kellogg Company Report.
Hershey has a great management team, Cramer said. It may seem like a boring stock, but in terms of growth, it is among the best in its group, he said, adding that Kellogg was the most dependable of all.
It is still possible that Bernanke will pull us out of this tailspin, Cramer said, but if he keeps raising rates, these three stocks should work. In a recession, these stocks should go up, but if Bernanke starts cutting rates, these three stocks could start going down, that's why you have to do your homework, Cramer told his viewers.
Hershey, McCormick and Kellogg are defensive stocks that were among the best performers the last time the Fed raised rates too high, in 2000-02, he said. The game plan for this week is defense. These are the three best supermarket stocks to own in case of a Fed-induced disaster.
The next area to invest in at the moment is drugstores. "You don't stop taking your medicine or buying Band-Aids, even if the economy goes down," he said.
One thing you do want to make sure of is that the drug companies you invest in have product patents because patents allow you to sleep at night. These are four drug companies that Cramer likes:
- Schering-Plough (SGP) , which he owns for his Action Alerts PLUS charitable trust
- Novartis (NVS) - Get Novartis AG Report
- Sanofi-Aventis (SNY) - Get Sanofi Report
- Johnson & Johnson (JNJ) - Get Johnson & Johnson Report
Schering-Plough has a great management team, and they are starting from nothing, Cramer said. The first three companies he listed all have patent protection on drugs, and that prevents competition from generic-drug makers, he said.
While the first three companies are drug manufacturers, said Cramer, Johnson & Johnson is all about the Band-Aids and Neutrogena shampoo.
While Cramer gave a caller the thumbs up for
Whole Foods Market
, he told two separate callers to look away from
Glaxo's Recession Protection
The new king of pharmacy, instead of
, Cramer said.
"If you want to buy one stock that protects you from the Bernanke onslaught, this is it," he said.
There are a lot of great reasons to buy Glaxo, said Cramer, but he believes there are two reasons in particular.
First, Glaxo has reportedly placed the highest bid for
consumer unit, about $15 billion.
"When we're dealing with over-the-counter stuff for drugstores, everything is a battle space," Cramer said.
The bigger over-the-counter brands Glaxo already has include Tums, Sensodyne and Aquafresh. If it wins the Pfizer bid, it will also acquire Listerine, Sudafed and Lubriderm.
The New York Times
wrote an article in April that said Glaxo has become the master of taking prescription drugs when they come on patent, messing around with them a little and making them into fabulous over-the-counter drugs.
Glaxo is also based in London, which provides it an extra layer of insulation from Bernanke, Cramer said.
Today the stock took a hit, so it is at a good entry point right now.
Cramer was bullish on
Cramer was bearish on
Burger King Holdings
Sirius Satellite Radio
For more of Cramer's insights during the most recent Lightning Round, click here.
Want more Cramer? Check out Jim's rules and commandments for investing from his latest book by
At the time of publication, Cramer was long Microsoft and Schering-Plough.
Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for TheStreet.com, Inc., and CNBC, and a director and co-founder of TheStreet.com. All opinions expressed by Mr. Cramer on Mad Money are his own and do not reflect the opinions of TheStreet.com or its affiliates, or CNBC, NBC UNIVERSAL or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither TheStreet.com, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or TheStreet.com is related to the specific opinions expressed by him on "Mad Money."
None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, TheStreet.com or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor TheStreet.com, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.
Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in TheStreet.com, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.